Our findings imply that increased palmitoleic acid (16:1n-7) proportion, a product related to SCD1(16) activity, not only increases the likelihood of abdominal fat accumulation, but also obesity-related metabolic abnormalities. The gene discussed is SCD; the disease is obesity due to melanocortin 4 receptor deficiency.